| 000 | 01815 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516083027.0 | ||
| 264 | 0 | _c20120730 | |
| 008 | 201207s 0 0 eng d | ||
| 022 | _a2210-7711 | ||
| 024 | 7 |
_a10.1007/s11096-012-9622-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aProvenzani, Alessio | |
| 245 | 0 | 0 |
_aUnusual high dose of tacrolimus in liver transplant patient, a case report. _h[electronic resource] |
| 260 |
_bInternational journal of clinical pharmacy _cApr 2012 |
||
| 300 |
_a269-71 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aATP Binding Cassette Transporter, Subfamily B |
| 650 | 0 | 4 |
_aATP Binding Cassette Transporter, Subfamily B, Member 1 _xgenetics |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aCytochrome P-450 CYP3A _xgenetics |
| 650 | 0 | 4 | _aDrug Monitoring |
| 650 | 0 | 4 |
_aGraft Rejection _ximmunology |
| 650 | 0 | 4 |
_aGraft Survival _xdrug effects |
| 650 | 0 | 4 | _aHomozygote |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aLiver Transplantation _ximmunology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPharmacogenetics |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 | _aPolymorphism, Single Nucleotide |
| 650 | 0 | 4 |
_aTacrolimus _xadministration & dosage |
| 650 | 0 | 4 | _aTissue Donors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aNotarbartolo, Monica | |
| 700 | 1 | _aLabbozzetta, Manuela | |
| 700 | 1 | _aPoma, Paola | |
| 700 | 1 | _aD'Antoni, Adele | |
| 700 | 1 | _aPolidori, Piera | |
| 700 | 1 | _aVizzini, Giovanni | |
| 700 | 1 | _aD'Alessandro, Natale | |
| 773 | 0 |
_tInternational journal of clinical pharmacy _gvol. 34 _gno. 2 _gp. 269-71 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s11096-012-9622-6 _zAvailable from publisher's website |
| 999 |
_c21627054 _d21627054 |
||